Table 5.
Relationship between the expression level of COL3A1 and clinical characteristics in ES.
| Characteristic | Low expression of COL3A1 | High expression of COL3A1 | p |
|---|---|---|---|
| n | 50 | 51 | |
| Metastasis, n (%) | 0.686 | ||
| No | 39 (38.6%) | 37 (36.6%) | |
| Yes | 11 (10.9%) | 14 (13.9%) | |
| Tumor region, n (%) | 0.920 | ||
| Distal | 19 (29.7%) | 17 (26.6%) | |
| Other | 1 (1.6%) | 2 (3.1%) | |
| Proximal | 13 (20.3%) | 12 (18.8%) | |
| Proximal and distal | 0 (0%) | 0 (0%) | |
| Age, n (%) | 0.371 | ||
| <18 | 41 (40.6%) | 37 (36.6%) | |
| ≥18 | 9 (8.9%) | 14 (13.9%) | |
| Gender, n (%) | 0.089 | ||
| Female | 25 (24.8%) | 16 (15.8%) | |
| Male | 25 (24.8%) | 35 (34.7%) | |
| Race, n (%) | |||
| American Indian or Alaska Native | 0 (0%) | 1 (1.3%) | |
| Asian | 3 (3.9%) | 4 (5.3%) | |
| Black or African American | 3 (3.9%) | 7 (9.2%) | |
| Native Hawaiian or other Pacific Islander | 0 (0%) | 0 (0%) | |
| White | 31 (40.8%) | 27 (35.5%) | |
| Age, median (IQR) | 15.12 (12.62, 17.33) | 15.1 (12.12, 18.41) | 0.973 |